Management of Malignant Small Bowel Obstruction: Is Intestinal Bypass Effective Palliation?
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
31
03
2022
accepted:
25
06
2022
pubmed:
22
7
2022
medline:
24
9
2022
entrez:
21
7
2022
Statut:
ppublish
Résumé
Malignant small bowel obstruction (mSBO) is a common consequence of advanced malignancies. Surgical consultation is common, however data on the outcomes following an operation are lacking. We investigated a specific operative approach-intestinal bypass-to determine the outcomes associated with this intervention. Patients with a preoperative diagnosis of mSBO who underwent intestinal bypass between 2015 and 2021 were included. Isolated colonic obstruction was excluded as was gastric outlet obstruction. Perioperative and postoperative outcomes were measured, including complications, overall survival, return to oral intake, and return to intended oncologic therapy. Patients were additionally grouped as to whether the operation was performed as elective or as inpatient. Overall, 55 patients were identified, with a mean age of 61.2 ± 14 years. The most common primary malignancy was colorectal cancer (65.5%) and 80% of patients had a preoperative diagnosis of metastatic disease. Small bowel to colon was the most common bypass procedure (51%). Severe complications occurred in 25.5% of patients with three in-hospital mortalities (5.5%). Survival rates at 30, 90, and 180 days were 91%, 80%, and 62%, respectively. The majority of patients were discharged to home (85.5%) and were tolerating an oral diet (74.6%). Twenty-seven patients (49.1%) returned to some form of oncologic treatment. Patients with mSBO face a potentially terminal condition. In this study, approximately 75% of patients who underwent intestinal bypass were able to regain the ability to eat, and 49% returned to oncologic therapy. Although retrospective, these data suggest the approach is efficacious for palliation of this difficult sequela of advanced cancer.
Sections du résumé
BACKGROUND/PURPOSE
OBJECTIVE
Malignant small bowel obstruction (mSBO) is a common consequence of advanced malignancies. Surgical consultation is common, however data on the outcomes following an operation are lacking. We investigated a specific operative approach-intestinal bypass-to determine the outcomes associated with this intervention.
METHODS
METHODS
Patients with a preoperative diagnosis of mSBO who underwent intestinal bypass between 2015 and 2021 were included. Isolated colonic obstruction was excluded as was gastric outlet obstruction. Perioperative and postoperative outcomes were measured, including complications, overall survival, return to oral intake, and return to intended oncologic therapy. Patients were additionally grouped as to whether the operation was performed as elective or as inpatient.
RESULTS
RESULTS
Overall, 55 patients were identified, with a mean age of 61.2 ± 14 years. The most common primary malignancy was colorectal cancer (65.5%) and 80% of patients had a preoperative diagnosis of metastatic disease. Small bowel to colon was the most common bypass procedure (51%). Severe complications occurred in 25.5% of patients with three in-hospital mortalities (5.5%). Survival rates at 30, 90, and 180 days were 91%, 80%, and 62%, respectively. The majority of patients were discharged to home (85.5%) and were tolerating an oral diet (74.6%). Twenty-seven patients (49.1%) returned to some form of oncologic treatment.
CONCLUSIONS
CONCLUSIONS
Patients with mSBO face a potentially terminal condition. In this study, approximately 75% of patients who underwent intestinal bypass were able to regain the ability to eat, and 49% returned to oncologic therapy. Although retrospective, these data suggest the approach is efficacious for palliation of this difficult sequela of advanced cancer.
Identifiants
pubmed: 35864366
doi: 10.1245/s10434-022-12204-w
pii: 10.1245/s10434-022-12204-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6980-6987Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. Society of Surgical Oncology.
Références
Banting SP, Waters PS, Peacock O, et al. Management of primary and metastatic malignant small bowel obstruction, operate or palliate. A systematic review. ANZ J Surg. 2021;91(3):282–90.
doi: 10.1111/ans.16188
Franke AJ, Iqbal A, Starr JS, Nair RM, George TJ Jr. Management of malignant bowel obstruction associated with GI cancers. J Oncol Pract. 2017;13(7):426–34.
doi: 10.1200/JOP.2017.022210
Song Y, Metzger DA, Bruce AN, et al. Surgical outcomes in patients with malignant small bowel obstruction: a national cohort study. Ann Surg. 2022;275(1):e198–205.
doi: 10.1097/SLA.0000000000003890
Badgwell BD, Smith K, Liu P, Bruera E, Curley SA, Cormier JN. Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation. Support Care Cancer. 2009;17(6):727–34.
doi: 10.1007/s00520-008-0554-6
Williams LA, Bruera E, Badgwell B. In search of the optimal outcome measure for patients with advanced cancer and gastrointestinal obstruction: a qualitative research study. Ann Surg Oncol. 2020;27(8):2646–52.
doi: 10.1245/s10434-020-08328-6
Alese OB, Kim S, Chen Z, Owonikoko TK, El-Rayes BF. Management patterns and predictors of mortality among US patients with cancer hospitalized for malignant bowel obstruction. Cancer. 2015;121(11):1772–8.
doi: 10.1002/cncr.29297
Badgwell BD, Contreras C, Askew R, Krouse R, Feig B, Cormier JN. Radiographic and clinical factors associated with improved outcomes in advanced cancer patients with bowel obstruction. J Palliat Med. 2011;14(9):990–6.
doi: 10.1089/jpm.2011.0083
Tuca A, Guell E, Martinez-Losada E, Codorniu N. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res. 2012;4:159–69.
doi: 10.2147/CMAR.S29297
Chicago Consensus Working G. The Chicago consensus on peritoneal surface malignancies: palliative care considerations. Ann Surg Oncol. 2020;27(6):1798-1804.
Miller P, John PR, Ganai S. How should surgical palliative success be defined? AMA J Ethics. 2021;23(10):E778-782.
doi: 10.1001/amajethics.2021.778
Lee KC, Sokas CM, Streid J, et al. Quality indicators in surgical palliative care: a systematic review. J Pain Symptom Manage. 2021;62(3):545–58.
doi: 10.1016/j.jpainsymman.2021.01.122
Stacey CL, Pai M, Novisky MA, Radwany SM. Revisiting “awareness contexts” in the 21st century hospital: How fragmented and specialized care shape patients’ Awareness of Dying. Soc Sci Med. 2019;220:212–8.
doi: 10.1016/j.socscimed.2018.10.028
Groff AC, Colla CH, Lee TH. Days spent at home: a patient-centered goal and outcome. New Eng J Med. 2016;375(17):1610–2.
doi: 10.1056/NEJMp1607206
Shen E, Rozema EJ, Haupt EC, et al. Assessing the concurrent validity of days alive and at home metric. J Am Geriatr Soc. 2021. https://doi.org/10.1111/jgs.17506 .
doi: 10.1111/jgs.17506
pubmed: 34676885
Suskind AM, Zhao S, Boscardin WJ, Smith A, Finlayson E. Time spent away from home in the year following high-risk cancer surgery in older adults. J Am Geriatr Soc. 2020;68(3):505–10.
doi: 10.1111/jgs.16344
Chesney TR, Haas B, Coburn NG, et al. Patient-centered time-at-home outcomes in older adults after surgical cancer treatment. JAMA Surg. 2020;155(11):e203754.
doi: 10.1001/jamasurg.2020.3754
Lilley EJ, Scott JW, Goldberg JE, et al. Survival, healthcare utilization, and end-of-life care among older adults with malignancy-associated bowel obstruction: comparative study of surgery, venting gastrostomy, or medical management. Ann Surg. 2018;267(4):692–9.
doi: 10.1097/SLA.0000000000002164
Pujara D, Chiang YJ, Cormier JN, Bruera E, Badgwell B. Selective approach for patients with advanced malignancy and gastrointestinal obstruction. J Am Coll Surg. 2017;225(1):53–9.
doi: 10.1016/j.jamcollsurg.2017.04.033
Shaw C, Bassett RL, Fox PS, et al. Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites. Ann Surg Oncol. 2013;20(2):497–505.
doi: 10.1245/s10434-012-2643-5
Francescutti V, Miller A, Satchidanand Y, Alvarez-Perez A, Dunn KB. Management of bowel obstruction in patients with stage IV cancer: predictors of outcome after surgery. Ann Surg Oncol. 2013;20(3):707–14.
doi: 10.1245/s10434-012-2662-2
Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML. Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surg. 2014;149(4):383–92.
doi: 10.1001/jamasurg.2013.4059
Wancata LM, Abdelsattar ZM, Suwanabol PA, Campbell DA Jr, Hendren S. Outcomes after surgery for benign and malignant small bowel obstruction. J Gastrointest Surg. 2017;21(2):363–71.
doi: 10.1007/s11605-016-3307-8
Legendre H, Vanhuyse F, Caroli-Bosc FX, Pector JC. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol. 2001;27(4):364–7.
doi: 10.1053/ejso.2001.1120
Englert ZP, White MA, Fitzgerald TL, Vadlamudi A, Zervoudakis G, Zervos EE. Surgical management of malignant bowel obstruction: at what price palliation? Am Surg. 2012;78(6):647–52.
doi: 10.1177/000313481207800616
Shariat-Madar B, Jayakrishnan TT, Gamblin TC, Turaga KK. Surgical management of bowel obstruction in patients with peritoneal carcinomatosis. J Surg Oncol. 2014;110(6):666–9.
doi: 10.1002/jso.23707
Ito Y, Fujitani K, Sakamaki K, et al. QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study. Gastric Cancer. 2021;24(5):1131–9.
doi: 10.1007/s10120-021-01179-4
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.
doi: 10.1097/SLA.0b013e3181b13ca2
Lis CG, Gupta D, Lammersfeld CA, Markman M, Vashi PG. Role of nutritional status in predicting quality of life outcomes in cancer: a systematic review of the epidemiological literature. Nutr J. 2012;11:27.
doi: 10.1186/1475-2891-11-27
Prost ADJ, Douard R, Malamut G, Mecheri F, Wind P. Small bowel obstruction in patients with a prior history of cancer: predictive findings of malignant origins. World J Surg. 2014;38(2):363–9.
doi: 10.1007/s00268-013-2303-3
Helyer LK, Law CH, Butler M, Last LD, Smith AJ, Wright FC. Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer. Ann Surg Oncol. 2007;14(4):1264–71.
doi: 10.1245/s10434-006-9303-6
McNiff KK, Caligiuri MA, Davidson NE, et al. Improving goal concordant care among 10 leading academic U.S. Cancer Hospitals: a collaboration of the alliance of dedicated cancer centers. Oncologist. 2021;26(7):533–6.
doi: 10.1002/onco.13850